Abstract |
Human neural progenitor cells (hNPCs) derived from the fetal cortex can be expanded in vitro and genetically modified through lentiviral transduction to secrete growth factors shown to have a neurotrophic effect in animal models of neurological disease. hNPCs survive and mature following transplantation into the central nervous system of large and small animals including the rat model of amyotrophic lateral sclerosis. Here we report that hNPCs engineered to express glial cell line-derived neurotrophic factor ( GDNF) survive long-term (7.5 months) following transplantation into the spinal cord of athymic nude rats and continue to secrete GDNF. Cell proliferation declined while the number of astrocytes increased, suggesting final maturation of the cells over time in vivo. Together these data show that GDNF-producing hNPCs may be useful as a source of cells for long-term delivery of both astrocytes and GDNF to the damaged central nervous system.
|
Authors | Geneviève Gowing, Brandon Shelley, Kevin Staggenborg, Amanda Hurley, Pablo Avalos, Jesse Victoroff, Jessica Latter, Leslie Garcia, Clive N Svendsen |
Journal | Neuroreport
(Neuroreport)
Vol. 25
Issue 6
Pg. 367-72
(Apr 16 2014)
ISSN: 1473-558X [Electronic] England |
PMID | 24284956
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glial Cell Line-Derived Neurotrophic Factor
- Glial Fibrillary Acidic Protein
|
Topics |
- Animals
- Cell Differentiation
(physiology)
- Cell Line
- Cell Survival
(physiology)
- Fetal Stem Cells
(metabolism, transplantation)
- Glial Cell Line-Derived Neurotrophic Factor
(metabolism)
- Glial Fibrillary Acidic Protein
(metabolism)
- Graft Survival
(physiology)
- Humans
- Male
- Neural Stem Cells
(metabolism, transplantation)
- Rats
- Rats, Nude
- Spinal Cord
(pathology, transplantation)
|